Pepgen Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pepgen inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pepgen Inc Today - Breaking & Trending Today

Reviewing PepGen (NASDAQ:PEPG) & Sage Therapeutics (NASDAQ:SAGE)

Sage Therapeutics (NASDAQ:SAGE – Get Free Report) and PepGen (NASDAQ:PEPG – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, dividends, valuation and profitability. Profitability This table compares Sage Therapeutics and PepGen’s […] ....

United States , South Korea , United Kingdom , Pepgen Inc , Sage Therapeutics Inc , Shionogi Co Ltd , Sterogen Biopharma Inc , Biogen Ma Inc , Sage Therapeutics , Get Free Report , Given Sage Therapeutic , Sterogen Biopharma , Amgen Inc , Sage Therapeutics Daily ,

Comparing PepGen (NASDAQ:PEPG) and Sage Therapeutics (NASDAQ:SAGE)

PepGen (NASDAQ:PEPG – Get Free Report) and Sage Therapeutics (NASDAQ:SAGE – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, profitability, risk and dividends. Earnings & Valuation This table compares PepGen and […] ....

United States , United Kingdom , South Korea , Pepgen Inc , Sterogen Biopharma Inc , Biogen Ma Inc , Shionogi Co Ltd , Sage Therapeutics Inc , Get Free Report , Sage Therapeutics , Sage Therapeutic , Given Sage Therapeutic , Amgen Inc , Sterogen Biopharma , Pepgen Daily ,

PepGen's (PEPG) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of PepGen (NASDAQ:PEPG – Free Report) in a research report released on Wednesday, Benzinga reports. The brokerage currently has a $26.00 price objective on the stock. HC Wainwright also issued estimates for PepGen’s Q2 2024 earnings at ($0.71) EPS, Q3 2024 earnings at ($0.72) EPS, Q4 2024 […] ....

Niels Svenstrup , Janus Henderson Group , Securities Exchange Commission , Pepgen Inc , Artal Group , Vanguard Group Inc , Free Report , Gen Stock Down , Get Free Report , Exchange Commission , Henderson Group , Capital Partners , Amgen Inc , Pepgen Daily ,